Author response: Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology

I thank Dr. Saltonstall for the comments and interest in this guideline.1 The development of a guideline covering 23 medications and 143 randomized trials, as well as 30-plus recommendations and multiple development steps, is complex to the point of being overwhelming. We appreciate Dr. Saltonstall’s careful reading of this document.

Source link

Related posts

Sleep Complaints, Sleep and Breathing Disorders in Myotonic Dystrophy Type 2.


Subthreshold amyloid and its biological and clinical meaning: Long way ahead


Telling Stories Using Rhythmic Gesture Helps Children Improve Oral Skills


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy